Recursion Pharmaceuticals, Inc () has held its Q3 earnings call. Read on for the main highlights of the call. Recursion Pharmaceuticals Earnings Call Highlights Clinical Momentum ...
On Thursday, Microsoft had a bad day. Problems with its infrastructure resulted in a widespread outage of Microsoft 365 ...
Sai Konkimalla, a 2026 summer intern at Jane Street, built a compiler for a domain-specific language that lets developers ...
Git security updates fix six flaws, including one that lets malicious repositories execute attacker code during recursive cloning.
For the past two years, the tech industry has been obsessed with AI copilots, assistants that write your code, draft... Read ...
Box ManipulationIn the history of artificial intelligence and machine learning, the determination of internal parameters ...
Understanding their capabilities can help developers and blockchain businesses choose tools that better match their technical ...
Together AI builds an agentic compiler to try and bring recursive self improvement capabilities to open source models.
On November 2, 2026, a blog post published by an MIT research team became a major topic among AI researchers. It claimed that ...
Recursion Pharmaceuticals (NASDAQ:RXRX) reported updated clinical data for its investigational treatment for familial ...
Recursion said it expects to launch its first registrational trial in the second half of this year for its lead candidate REC-4881 based on talks with the FDA, after the oral familial adenomatous ...
RXRX Q3 revenues surge 258.5%, beating estimates as a $10 million Sanofi milestone payment boosts results and advances its drug pipeline.